Clinical Trial: Presentation of Young Adults With and Without Joint Hypermobility

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657507) titled 'Presentation of Young Adults With and Without Joint Hypermobility' on June 15.

Brief Summary: People with multiple hypermobile joints are diagnosed with Generalized Joint Hypermobility (GJH) when asymptomatic, or Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD) when symptomatic (hEDS/HSD, or 'HSD' in this document).(Russek, 2019) GJH likely affects about 20% of the U.S. population, while HSD affects 0.5-3% of the US population. Although joint hypermobility is the most visible presentation of HSD, it is a systemic connective tissue disorder affecting multiple body systems. Due to frequent health con...